Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (91-100 of 177) with videos related to

Pageof 18
Sort By:
Plos One|December 20, 2016
Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLDJohannie du Plessis, Hannelie Korf, Jos van Pelt, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2020
Plasma BCAA Changes in Patients With NAFLD Are Sex DependentGuillaume Grzych, Luisa Vonghia, Marie-Adélaïde Bout, et al.
Diseases (Basel, Switzerland)|August 28, 2024
Practice Recommendations for the Management of MASLD in Primary Care: Consensus ResultsChristos Lionis, Sophia Papadakis, Marilena Anastasaki, et al.
Clinical Epigenetics|August 14, 2021
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver diseaseSara Diels, Bart Cuypers, Asta Tvarijonaviciute, et al.
Cellular Immunology|February 6, 2021
Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infectionsStijn Van Hees, Bart Cuypers, Stefan Bourgeois, et al.
Journal of Hepatology|January 18, 2015
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4Christophe Moreno, Christophe Hezode, Patrick Marcellin, et al.
International Journal of Obesity (2005)|December 23, 2023
The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver diseaseAnnelies Van Eyck, Wilhelmus J Kwanten, Cédric Peleman, et al.
Hepatology (Baltimore, Md.)|January 17, 2020
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyVlad Ratziu, Arun Sanyal, Stephen A Harrison, et al.
Journal of Hepatology|November 5, 2022
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASHVlad Ratziu, Stephen A Harrison, Véronique Loustaud-Ratti, et al.
Plos One|August 24, 2017
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screeningAnja De Weggheleire, Sokkab An, Irith De Baetselier, et al.
Pageof 18

Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Plos One|December 20, 2016
Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLDJohannie du Plessis, Hannelie Korf, Jos van Pelt, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2020
Plasma BCAA Changes in Patients With NAFLD Are Sex DependentGuillaume Grzych, Luisa Vonghia, Marie-Adélaïde Bout, et al.
Diseases (Basel, Switzerland)|August 28, 2024
Practice Recommendations for the Management of MASLD in Primary Care: Consensus ResultsChristos Lionis, Sophia Papadakis, Marilena Anastasaki, et al.
Clinical Epigenetics|August 14, 2021
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver diseaseSara Diels, Bart Cuypers, Asta Tvarijonaviciute, et al.
Cellular Immunology|February 6, 2021
Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infectionsStijn Van Hees, Bart Cuypers, Stefan Bourgeois, et al.
Journal of Hepatology|January 18, 2015
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4Christophe Moreno, Christophe Hezode, Patrick Marcellin, et al.
International Journal of Obesity (2005)|December 23, 2023
The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver diseaseAnnelies Van Eyck, Wilhelmus J Kwanten, Cédric Peleman, et al.
Hepatology (Baltimore, Md.)|January 17, 2020
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyVlad Ratziu, Arun Sanyal, Stephen A Harrison, et al.
Journal of Hepatology|November 5, 2022
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASHVlad Ratziu, Stephen A Harrison, Véronique Loustaud-Ratti, et al.
Plos One|August 24, 2017
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screeningAnja De Weggheleire, Sokkab An, Irith De Baetselier, et al.
Pageof 18